Kazia Therapeutics Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Kazia Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $29.17. The average 1-year stock price forecast is 130.96% higher than the current stock price, while the lowest is $17.91 (+41.81%) and the highest is $39.94 (+216.23%).

Price Target: $29.17 (+130.96%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$17.91	$29.17	$29.8	$39.94
Change	+41.81%	+130.96%	+135.95%	+216.23%

Analyst Ratings

The average analyst rating for Kazia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	1	1	2	3	4	4
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	4	5	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kambiz Yazdi BTIG	BTIG	Buy Reiterates $34 → $40	Buy	Reiterates	$34 → $40	+216.71%	Sep 1, 2026
John Newman Canaccord Genuity	Canaccord Genuity	Buy Maintains $29	Buy	Maintains	$29	+129.61%	Aug 31, 2026
Naz Rahman Maxim Group	Maxim Group	Buy Reiterates $30	Buy	Reiterates	$30	+137.53%	Jul 16, 2026
Chad Messer Lake Street	Lake Street	Buy Initiates $32	Buy	Initiates	$32	+153.37%	Jun 11, 2026
Sean Lee CFA H.C. Wainwright	H.C. Wainwright	Buy Reiterates $18	Buy	Reiterates	$18	+42.52%	Jun 3, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

407.33K

from 1.83M

-77.73%

from 1.83M

Revenue Next Year

96.67K

from 407.33K

-76.27%

from 407.33K

EPS This Year

-0.05

from -

EPS Next Year

n/a

from -0.05

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	15.18M	10.00K	1,000.00	2.48M	1.83M	407.33K
Revenue Growth	1,436.54%	-99.93%	-90.00%	248,000.00%	-26.28%	-77.73%
Operating Income	-6.38M	-25.38M	-24.15M	-28.46M	-14.22M	-25.38M
Net Income	-8.42M	-25.01M	-20.47M	-26.78M	-20.70M	-25.69M
EPS	-	-	-	-	-	-0.05
Free Cash Flow	1.26M	-16.04M	-14.62M	5.05M	-14.91M	-27.11M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	508,000
Avg	407,330
Low	253,000

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-72.2%
Avg	-77.7%
Low	-86.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.05
Avg	-0.05
Low	-0.05

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-